Poolbeg Pharma has dosed the first patient in a clinical [...]

FORE Biotherapeutics has completed target enrolment in the primary central [...]

Compass Pathways has reported positive six-month results from its second [...]

EnteroBiotix has dosed the first patient in its Phase 2b [...]

Grifols has dosed the first participant in a Phase 3 [...]

Resalis Therapeutics has dosed the first participant in a Phase [...]

Absci has reported positive interim Phase 1 data for ABS-201, [...]

Medicus Pharma has submitted an investigational new drug application in [...]

Poolbeg Pharma has activated the first clinical site and begun [...]

CONNECTA Therapeutics has started a Phase 2a clinical trial of [...]